Our goal is understanding health focused on research of infection mechanisms and maintaining health by providing innovative customized drugs as well as developing new processes and methods in drug production and testing. We work on scientific approaches to make biological processes predictable and research the cost-effective production of patient-specific drugs.
Our research brings together scientists from biology, chemistry, pharmaceutics, physics, mathematics, computer science, process and production engineering, and microtechnology. This enables us to map the entire value chain - from research into the molecular basis of infections and possible drug targets, to drug development, formulation, production and packaging. This interdisciplinary know-how is unique in the German research landscape.
TU Braunschweig and the University of São Paulo have launched ...
The results of the “Strategically developing potential” call have been ...
On 1 February 2025, Julian Hegemann was appointed Professor at ...
